Evidence map›Paper›PMID 33284502›Full record

ArticleHepatology (Baltimore, Md.)2021

Metabolic Landscape of the Mouse Liver by Quantitative

Ganeko Bernardo-Seisdedos, Jon Bilbao, David Fernández-Ramos, Fernando Lopitz-Otsoa, Virginia Gutierrez de Juan, Maider Bizkarguenaga, Borja Mateos, Marcos F Fondevila, Jordi Abril-Fornaguera, Tammo Diercks and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Structural dynamics (Melville, N.Y.) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. CD9 Counteracts Liver Steatosis and Mediates GCGR Agonist Hepatic Effects.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Review
  7. Quantitative Analysis of the Human Semen Phosphorometabolome byInternational journal of molecular sciences · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Ganeko Bernardo-Seisdedos *Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance, Parque Tecnológico de Bizkaia, Derio, Spain.
Jon Bilbao *Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance, Parque Tecnológico de Bizkaia, Derio, Spain.
David Fernández-RamosPrecision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance, Parque Tecnológico de Bizkaia, Derio, Spain.
Fernando Lopitz-OtsoaPrecision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance, Parque Tecnológico de Bizkaia, Derio, Spain.
Virginia Gutierrez de JuanPrecision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance, Parque Tecnológico de Bizkaia, Derio, Spain.
Maider BizkarguenagaPrecision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance, Parque Tecnológico de Bizkaia, Derio, Spain.
Borja MateosPrecision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance, Parque Tecnológico de Bizkaia, Derio, Spain.
Marcos F FondevilaDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.ORCID 0000-0002-5099-3421
Jordi Abril-FornagueraLiver Cancer Translational Research Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain.ORCID 0000-0002-5871-4052
Tammo DiercksNMR Platform, CIC bioGUNE, Basque Research and Technology Alliance, Parque Tecnológico de Bizkaia, Bizkaia, Spain.
Shelly C LuDivision of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.
Rubén NogueirasDepartment of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
José M MatoPrecision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance, Parque Tecnológico de Bizkaia, Derio, Spain.
Oscar MilletPrecision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance, Parque Tecnológico de Bizkaia, Derio, Spain.ORCID 0000-0001-8748-4105
CIC bioGUNE · ESInstituto de Salud Carlos III · ESUniversidade de Santiago de Compostela · ESCedars-Sinai Medical Center · USConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESUniversity of Vienna · AT

Funding

Role of SAMe in the Progression of Nonalcoholic Fatty Liver DiseaseR01DK123763 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI LU, SHELLY CHI-LOO · 2020 to 2024
$2.1M
NIDDK NIH HHS R01 DK123763
6 · The paper itself

Abstract

BACKGROUND AND

aimsThe liver plays a central role in all metabolic processes in the body. However, precise characterization of liver metabolism is often obscured by its inherent complexity. Phosphorylated metabolites occupy a prominent position in all anabolic and catabolic pathways. Here, we develop a APPROACH AND

resultsWe applied this technique to define the metabolic landscape in livers from a mouse model of the rare disease disorder congenital erythropoietic porphyria (CEP) as well as two well-known murine models of nonalcoholic steatohepatitis: one genetic, methionine adenosyltransferase 1A knockout mice, and the other dietary, mice fed a high-fat choline-deficient diet. We report alterations in the concentrations of phosphorylated metabolites that are readouts of the balance between glycolysis, gluconeogenesis, the pentose phosphate pathway, the tricarboxylic acid cycle, and oxidative phosphorylation and of phospholipid metabolism and apoptosis. Moreover, these changes correlate with the main histological features: steatosis, apoptosis, iron deposits, and fibrosis. Strikingly, treatment with the repurposed drug ciclopirox improves the phosphoromic profile of CEP mice, an effect that was mirrored by the normalization of liver histology.

conclusionsIn conclusion, these findings indicate that NMR-based phosphoromics may be used to unravel metabolic phenotypes of liver injury and to identify the mechanism of drug action.

Indexed as

AnimalsDisease Models, AnimalFeasibility StudiesFemaleHumansHydrophobic and Hydrophilic InteractionsLiverMagnetic Resonance SpectroscopyMaleMetabolomeMetabolomicsMiceMice, TransgenicModels, AnimalNon-alcoholic Fatty Liver DiseasePhosphorusPhosphorus

Identifiers

PMID33284502
PMCPMC8362057
OpenAlexW3111435210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.